Msb, One harvest = thousands of doses @ $100k + seems ok to me.we have ipsc tech, Si said the cost/benefit difference was marginal but I agree it could be better. Long way to go for proof!
you cant compare msb study of really sick patients vs cyp study with lessor sick patients. Or p1 vs p3 completed
msb can deliver mass produced cells
ps I only responded because it’s annoying when people keep trotting out garbage when fellow cyp lovers know the truth but won’t correct anyone
Ann: Cynata Extends FUJIFILM Licence Option in GvHD, page-218
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.90M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 25.0¢ | $6.12K | 24.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27889 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 4790 | 2 |
View Market Depth
| Last trade - 15.10pm 15/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |